Citigroup’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.4K | Sell |
31,710
-99,527
| -76% | -$259K | ﹤0.01% | 3778 |
|
|
2025
Q1 | $249K | Buy |
131,237
+52,634
| +67% | +$100K | ﹤0.01% | 3310 |
|
|
2024
Q4 | $114K | Buy |
78,603
+4,322
| +6% | +$6.27K | ﹤0.01% | 3925 |
|
|
2024
Q3 | $137K | Buy |
74,281
+51,150
| +221% | +$94.1K | ﹤0.01% | 3843 |
|
|
2024
Q2 | $23.1K | Buy |
23,131
+6,089
| +36% | +$6.09K | ﹤0.01% | 4224 |
|
|
2024
Q1 | $33.7K | Buy |
17,042
+3,640
| +27% | +$7.21K | ﹤0.01% | 4087 |
|
|
2023
Q4 | $20.9K | Buy |
13,402
+13,219
| +7,223% | +$20.6K | ﹤0.01% | 4220 |
|
|
2023
Q3 | $361 | Sell |
183
-28,905
| -99% | -$57K | ﹤0.01% | 4486 |
|
|
2023
Q2 | $92.5K | Sell |
29,088
-113,853
| -80% | -$362K | ﹤0.01% | 3619 |
|
|
2023
Q1 | $467K | Buy |
142,941
+16,626
| +13% | +$54.4K | ﹤0.01% | 2577 |
|
|
2022
Q4 | $635K | Buy |
126,315
+121,782
| +2,687% | +$613K | ﹤0.01% | 2368 |
|
|
2022
Q3 | $10K | Buy |
4,533
+3,163
| +231% | +$6.98K | ﹤0.01% | 4240 |
|
|
2022
Q2 | $4K | Buy |
+1,370
| New | +$4K | ﹤0.01% | 4886 |
|
|
2022
Q1 | – | Sell |
-37,834
| Closed | -$120K | – | 5469 |
|
|
2021
Q4 | $120K | Buy |
+37,834
| New | +$120K | ﹤0.01% | 3876 |
|